financial

GeneSight mental health monitor reveals gap in frontline mental health care |  MarketScreener

APPLIED GENETIC TECHNOLOGIES CORP MANAGEMENT REPORT OF FINANCIAL POSITION AND RESULTS OF OPERATIONS (Form 10-Q) | MarketScreener

The following discussion and analysis provide an overview of our financial condition as of September 30, 2022 and our results of operations for the three months ended September 30, 2022 and 2021. This discussion should be read in conjunction with the Unaudited Condensed Financial Statements and related notes included in this Quarterly Report on Form …

APPLIED GENETIC TECHNOLOGIES CORP MANAGEMENT REPORT OF FINANCIAL POSITION AND RESULTS OF OPERATIONS (Form 10-Q) | MarketScreener Read More »

UroSuite from Myriad Genetics (MYGN) to enhance tailored treatment

UroSuite from Myriad Genetics (MYGN) to enhance tailored treatment

Myriad Genetics, Inc. (Quick quote MYGNMYGN – Free Report) recently announced the launch of UroSuite, a comprehensive suite of genetic risk assessment tests covering all stages of prostate cancer care. The UroSuite includes the company’s Prolaris prostate cancer test, MyRisk hereditary cancer test, BRACAnalysis CDx, and accurate tumor molecular profiling test. The latest launch is …

UroSuite from Myriad Genetics (MYGN) to enhance tailored treatment Read More »